Records containing: Renal Cell Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-06-22Comparison of Laparoscopic Partial Nephrectomy Versus Laparoscopic Radical Nephrectomy in Patients With High-Complexity Renal Tumors: A Propensity Score Matched Analysis
-
CLINICAL_TRIALS study record update · 2021-06-03A Phase 2, Multicenter, Randomized, Single-Blind Study of Vitespen (HSPPC-96, Oncophage) for Immune Response Assessment Following Treatment of Patients With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence
-
CLINICAL_TRIALS study record update · 2021-05-28A Rollover Protocol For Patients Who Received Tremelimumab (CP-675,206 ) In Other Protocols
-
CLINICAL_TRIALS study record update · 2021-05-19Provider Referral Patterns Following Nephrectomy in High-Risk Locoregional Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2021-05-07A Retrospective Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-04-06Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell Carcinoma: A Non-inferiority Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-04-05Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
-
CLINICAL_TRIALS study record update · 2021-03-25Open-labeled, Multicenter, Non-interventional, Prospective PRO Registry for Patients With First Line Treatment for Advanced RCC Using a Tablet-technology Based Digital Device
-
CLINICAL_TRIALS study record update · 2021-03-19Brivanib (BMS-582664, Brivanib Alaninate) in Treatment of Refractory Metastatic Renal Cell Carcinoma - A Phase II Pharmacodynamic and Baseline Biomarker Study
-
CLINICAL_TRIALS study record update · 2021-03-163D Assessment of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy
-
CLINICAL_TRIALS study record update · 2021-03-05A Randomized, Open-Label (Formerly Double-Blind), Phase 2 Trial to Assess Safety and Efficacy of Lenvatinib at Two Different Starting Doses (18 mg vs. 14 mg QD) in Combination With Everolimus (5 mg QD) in Renal Cell Carcinoma Following One Prior VEGF-Targeted Treatment
-
CLINICAL_TRIALS study record update · 2021-03-03A Phase I Trial of Vaccination With Autologous, Lethally Irradiated Tumor Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Colony Stimulating Factor in Pediatric and Adult Patients
-
CLINICAL_TRIALS study record update · 2021-02-24A Phase II Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2021-02-12Vessels Encapsulating Tumor Clusters (VETC), Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Gland Carcinoma
-
CLINICAL_TRIALS study record update · 2021-02-01Treatment Patterns and Outcomes Among Advanced Renal Cell Carcinoma (aRCC) Patients Treated With Cabozantinib or Axitinib Therapy: Non Interventional, Retrospective Study Using Data From Public Health England's Cancer Analysis System
-
CLINICAL_TRIALS study record update · 2021-01-26Phase I/II Trial of Vandetanib in Combination With Metformin in Subjects With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2021-01-153D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement
-
CLINICAL_TRIALS study record update · 2021-01-07LCCC 1213: Defining Molecular and Functional Imaging Correlates of Renal Cell Carcinoma Biological Features
-
CLINICAL_TRIALS study record update · 2021-01-05Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)
-
CLINICAL_TRIALS study record update · 2020-12-31Case-Control Study of Renal Cell Cancer Among Caucasians and African Americans in the United States
-
CLINICAL_TRIALS study record update · 2020-12-23A Phase 2 Pilot Study of the Efficacy and Safety of Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.
-
CLINICAL_TRIALS study record update · 2020-12-21CAROLINE: An Observational, Prospective, Multicenter Study, on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase 1b/2 Study of Ramucirumab in Combination With LY2875358 in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2020-12-08A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
-
CLINICAL_TRIALS study record update · 2020-12-08A Phase I, Multicenter, Open-label Dose Escalation and Expansion Study of HKT288, Administered Intravenously in Adult Patients With Advanced Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma